For: | Wang HQ, Qian CH, Guo ZY, Li PM, Qiu ZJ. Long noncoding RNA negative regulator of antiviral response contributes to pancreatic ductal adenocarcinoma progression via targeting miR-299-3p. World J Gastroenterol 2022; 28(35): 5141-5153 [PMID: 36188725 DOI: 10.3748/wjg.v28.i35.5141] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v28/i35/5141.htm |
Number | Citing Articles |
1 |
JUN LIU, WENLI LI, RUYUE LU, JIAQING XU, CHUNHUI JIANG, JUNLIN DUAN, LINGZHI ZHANG, GUANFU WANG, JIAXI CHEN. Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma. Oncology Research 2024; 32(4): 717 doi: 10.32604/or.2023.043575
|
2 |
Yuchen Wu, Dongdong Wang, Jie Zhao, Jinhui Guo, Zhenyu Gao, Qiuran Xu, Xiaoge Hu. NRAV promoted the malignant progression of gastric cancer. Gene 2025; 937: 149134 doi: 10.1016/j.gene.2024.149134
|
3 |
Hui Lei, Tao Xiang, Hua Zhu, Xinyao Hu. A Novel Cholesterol Metabolism-Related lncRNA Signature Predicts the Prognosis of Patients with Hepatocellular Carcinoma and Their Response to Immunotherapy. Frontiers in Bioscience-Landmark 2024; 29(3) doi: 10.31083/j.fbl2903129
|
4 |
Huili Ren, Jianglin Zheng, Ying Zhu, Leiyun Wang, Jianmin Liu, Hongfeng Xu, Junli Dong, Shaohui Zhang. Comprehensive analysis of cuproptosis-related long non-coding RNAs in prognosis, immune microenvironment infiltration and chemotherapy response of hepatocellular carcinoma. Medicine 2023; 102(50): e36611 doi: 10.1097/MD.0000000000036611
|
5 |
Tian Zhan, Wei Wang, Xiao Guan, Wei Bao, Na Lu, Jianping Zhang. Construction of an m6A- and neutrophil extracellular traps-related lncRNA model to predict hepatocellular carcinoma prognosis and immune landscape. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1231543
|